한빛사논문
건국대학교 의과대학
Koh, Jung-Min MD*; Song, Keeho MD†; Kwak, Mi Kyung MD‡; Suh, Sunghwan MD§; Kim, Beom-Jun MD*; Sung, Tae-Yon MD∥; Hong, Jun Hyuk MD¶; Jeong, Byong Chang MD#; Kim, Jae Hyeon MD**; Lee, Seung Hun MD*
*Division of Endocrinology and Metabolism, Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
†Division of Endocrinology and Metabolism, Department of Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea
‡Division of Endocrinology and Metabolism, Hallym University Dongtan Sacred Heart Hospital, Dongtan, Korea
§Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea
∥Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul Korea
¶Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
#Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
**Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
J-MK and KS are joint first authors.
JHK and SHL are the corresponding authors.
Abstract
Objective: To assess the metabolic effects of adrenalectomy in patients with mild autonomous cortisol secretion (MACS).
Background: Despite retrospective studies showing the association of adrenalectomy for MACS with beneficial metabolic effects, there have been only two randomized prospective studies with some limitations to date.
Methods: A prospective, multicenter study randomized 132 patients with adrenal incidentaloma without any features of Cushing's syndrome but with serum cortisol>50 nmol/L after a 1 mg overnight dexamethasone suppression test (F-1mgODST) into an adrenalectomy group (n=66) or control group (n=66). The primary outcomes were changes in body weight, glucose, and blood pressure (BP).
Results: Among the 118 participants who completed the study with a median follow-up duration of 48 months (range: 3-66), the adrenalectomy group (n=46) exhibited a significantly higher frequency of improved weight control, glucose control, and BP control (32.6%, 45.7%, and 45.7%, respectively) compared to the control group (n=46; 6.5%, P=0.002; 15.2%, P=0.002; and 23.9%, P=0.029, respectively) after matching for age and sex. Adrenalectomy (odds ratio [OR]=10.38, 95% confidence interval [95% CI]=2.09-51.52, P=0.004), body mass index (OR=1.39, 95% CI=1.08-1.79, P=0.010), and F-1mgODST levels (OR=92.21, 95% CI=5.30-1604.07, P=0.002) were identified as independent factors associated with improved weight control. Adrenalectomy (OR=5.30, 95% CI=1.63-17.25, P=0.006) and diabetes (OR=8.05, 95% CI=2.34-27.65, P=0.001) were independently associated with improved glucose control. Adrenalectomy (OR=2.27, 95% CI=0.87-5.94, P=0.095) and hypertension (OR=10.77, 95% CI=3.65-31.81, P<0.001) demonstrated associations with improved BP control.
Conclusions: Adrenalectomy improved weight, glucose, and BP control in patients with MACS.
논문정보
관련 링크
연구자 키워드
연구자 ID
관련분야 연구자보기
관련분야 논문보기